Morgan Stanley
BSX.PRA

Morgan Stanley’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Morgan Stanley’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$272K Sell
2022
Q4 		$3.31M Buy
2022
Q3 		$289K Sell
2022
Q2 		$527K Sell
2022
Q1 		$5.77M Buy
2021
Q4 		$626K Buy
2020
Q4 		– Sell
2020
Q3 		$212K Sell
2020
Q2 		$230K Buy